Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,713,792
New position
Shares Held
424,191
first reported quarter
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 403 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $344,568,608 across 24 Biotechnology names. IBRX ranks #21 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
143,881 | $71,470,008 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,332 | $40,737,114 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
111,381 | $20,859,433 | |
| 4 | TECH |
BIO-TECHNE Corp
|
293,165 | $20,712,105 | |
| 5 | ARGX |
Argenx SE
|
22,193 | $20,589,999 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
58,666 | $17,660,224 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
307,103 | $17,572,433 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
55,002 | $15,673,919 |
All Filings in IBRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,713,792 | 424,191 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||